Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2018-09-06 2018-08-25
Drug Identification Number 02244475 02244475
Brand name DIPYRIDAMOLE INJECTION, USP DIPYRIDAMOLE INJECTION, USP
Common or Proper name Dipyridamole Injection Dipyridamole Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients DIPYRIDAMOLE DIPYRIDAMOLE
Strength(s) 5MG 5MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10mL 10mL
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-08-24 2018-08-24
Actual start date
Estimated end date 2018-09-05 2018-09-05
Actual end date 2018-09-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Dipyridamole Injection, USP 5 mg/mL 10 mL Vial will be available at all distribution centers effective today, Wednesday, September 5, 2018. Please note that the stockout date may vary by region; please check your local distribution centre for stock availability. If you have any questions or concerns, please do not hesitate to contact customer service at (877) 821-7724.
Health Canada comments